Oxford Biomedica is continuing to decline following last Monday's announcement of its £20m placing and open offer at 5p a share. The share price has fallen by nearly one-third since 10 December. In contrast, NXT has risen 18% in the past week. This follows the announcement of the proposed appointment of Dr David Bramwell as non-executive chairman on 1 January. NXT is changing its name to HiWave Technologies. FTSE TechMARK - RisersAEA Technology Group (AAT) 6.57p +9.87%NXT (NTX) 4.13p +6.44%Renovo Group (RNVO) 62.50p +5.93%Optos (OPTS) 175.00p +2.94%KCOM Group (KCOM) 58.25p +2.19%Promethean World (PRW) 58.50p +1.74%BT Group (BT.A) 185.30p +1.59%Vislink (VLK) 23.00p +1.10%Alterian (ALN) 192.00p +0.52%Ricardo (RCDO) 290.00p +0.52%FTSE TechMARK - FallersOxford Biomedica (OXB) 5.43p -6.38%Antisoma (ASM) 6.00p -5.51%Psion (PON) 94.50p -3.57%Kofax (KFX) 276.25p -3.07%Telecity Group (TCY) 479.00p -3.00%Vernalis (VER) 36.00p -2.70%Sinclair Pharma (SPH) 39.25p -1.88%RM (RM.) 170.75p -1.44%Autonomy Corporation (AU.) 1,521.00p -1.43%Torotrak (TRK) 22.25p -1.11%